Xeloda and Interstitial lung disease - from FDA reports


Summary

Interstitial lung disease is found among people who take Xeloda, especially for people who are female, 60+ old , have been taking the drug for 1 - 6 months, also take medication Tykerb, and have Breast cancer . We study 27,913 people who have side effects while taking Xeloda from FDA. Among them, 258 have Interstitial lung disease. Find out below who they are, when they have Interstitial lung disease and more.

What to expect?

If you take Xeloda and have Interstitial lung disease, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Xeloda and have Interstitial lung disease

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Xeloda

Xeloda has active ingredients of capecitabine. It is often used in breast cancer metastatic. (latest outcomes from Xeloda 28,221 users)

Interstitial Lung Disease

Interstitial lung disease has been reported by people with rheumatoid arthritis, high blood pressure, preventive health care, lung cancer - non-small cell, breast cancer (latest reports from 28,509 Interstitial lung disease patients).

On Feb, 03, 2017

27,913 people reported to have side effects when taking Xeloda.
Among them, 258 people (0.92%) have Interstitial Lung Disease


Number of reports submitted per year:

Could Xeloda cause Interstitial lung disease?

Time on Xeloda when people have Interstitial Lung Disease *:

  • < 1 month: 38.89 %
  • 1 - 6 months: 40.97 %
  • 6 - 12 months: 15.97 %
  • 1 - 2 years: 2.08 %
  • 2 - 5 years: 2.08 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Interstitial Lung Disease when taking Xeloda *:

  • female: 61.04 %
  • male: 38.96 %

Age of people who have Interstitial Lung Disease when taking Xeloda *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 3.24 %
  • 30-39: 0.93 %
  • 40-49: 7.87 %
  • 50-59: 20.37 %
  • 60+: 67.59 %

Top conditions involved for these people *:

  • Breast Cancer (72 people, 27.91%)
  • Breast Cancer Metastatic (37 people, 14.34%)
  • Colon Cancer (34 people, 13.18%)
  • Preventive Health Care (26 people, 10.08%)
  • High Blood Pressure (25 people, 9.69%)

Top co-used drugs for these people *:

  • Tykerb (65 people, 25.19%)
  • Herceptin (51 people, 19.77%)
  • Avastin (50 people, 19.38%)
  • Zometa (45 people, 17.44%)
  • Oxaliplatin (32 people, 12.40%)

Top other side effects for these people *:

  • Breathing Difficulty (60 people, 23.26%)
  • Osteonecrosis Of Jaw (34 people, 13.18%)
  • Stomatitis (31 people, 12.02%)
  • Pain (29 people, 11.24%)
  • Osteomyelitis (27 people, 10.47%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Interstitial lung disease when taking Xeloda?

Browse all side effects of Xeloda

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Interstitial lung disease

Interstitial lung disease

Could your condition cause Interstitial lung disease

Interstitial lung disease

Related studies

Can you answer these questions?

More questions for: Xeloda, Interstitial lung disease

You may be interested in these reviews

More reviews for: Xeloda, Interstitial lung disease